$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 10 11 12 13 14 15 16 17 18 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.07 | 55 | 3,359 | 5,295 | 5.4 K to 5.3 K (-1.03 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.05 | 42 | 2,564 | 5,350 | 5.4 K to 5.4 K (-0.78 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 61.00 | 323 | 19,703 | 5,392 | 5.7 K to 5.4 K (-5.65 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.96 | 1,387 | 84,552 | 5,715 | 7.1 K to 5.7 K (-19.53 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.83 | 15 | 912 | 7,102 | 7.1 K to 7.1 K (-0.21 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.81 | 28 | 1,703 | 7,117 | 7.1 K to 7.1 K (-0.39 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.80 | 69 | 4,195 | 7,145 | 7.2 K to 7.1 K (-0.96 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.78 | 14 | 851 | 7,214 | 7.2 K to 7.2 K (-0.19 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.77 | 28 | 1,702 | 7,228 | 7.3 K to 7.2 K (-0.39 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.76 | 48 | 2,916 | 7,256 | 7.3 K to 7.3 K (-0.66 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 60.75 | 49 | 2,977 | 7,304 | 7.4 K to 7.3 K (-0.67 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 30.74 | 2,300 | 70,702 | 7,353 | 5.1 K to 7.4 K (+45.52 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,053 | 4.3 K to 5.1 K (+18.75 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 3,600 | 85,860 | 83,700 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 63.00 | 2,365 | 148,995 | 11,970 | 14.3 K to 12 K (-16.50 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 3,600 | 85,860 | 14,335 | 10.7 K to 14.3 K (+33.54 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 8,350 | 43,838 | 7,650 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.83 | 337 | 20,837 | 34,199 | 34.5 K to 34.2 K (-0.98 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.75 | 75 | 4,631 | 34,536 | 34.6 K to 34.5 K (-0.22 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.60 | 598 | 36,837 | 34,611 | 35.2 K to 34.6 K (-1.70 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.55 | 299 | 18,403 | 35,209 | 35.5 K to 35.2 K (-0.84 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.30 | 150 | 9,195 | 35,508 | 35.7 K to 35.5 K (-0.42 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.25 | 37 | 2,266 | 35,658 | 35.7 K to 35.7 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.19 | 37 | 2,264 | 35,695 | 35.7 K to 35.7 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.18 | 150 | 9,177 | 35,732 | 35.9 K to 35.7 K (-0.42 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.11 | 37 | 2,261 | 35,882 | 35.9 K to 35.9 K (-0.10 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.10 | 971 | 59,328 | 35,919 | 36.9 K to 35.9 K (-2.63 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.09 | 112 | 6,842 | 36,890 | 37 K to 36.9 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.07 | 150 | 9,161 | 37,002 | 37.2 K to 37 K (-0.40 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.05 | 112 | 6,838 | 37,152 | 37.3 K to 37.2 K (-0.30 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 61.00 | 872 | 53,192 | 37,264 | 38.1 K to 37.3 K (-2.29 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.96 | 3,739 | 227,929 | 38,136 | 41.9 K to 38.1 K (-8.93 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.83 | 38 | 2,312 | 41,875 | 41.9 K to 41.9 K (-0.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.81 | 75 | 4,561 | 41,913 | 42 K to 41.9 K (-0.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.80 | 187 | 11,370 | 41,988 | 42.2 K to 42 K (-0.44 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.78 | 37 | 2,249 | 42,175 | 42.2 K to 42.2 K (-0.09 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.77 | 75 | 4,558 | 42,212 | 42.3 K to 42.2 K (-0.18 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.76 | 106 | 6,441 | 42,287 | 42.4 K to 42.3 K (-0.25 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 60.75 | 156 | 9,477 | 42,393 | 42.5 K to 42.4 K (-0.37 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 5.25 | 8,350 | 43,838 | 42,549 | 34.2 K to 42.5 K (+24.42 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 467 | 10,064 | 3,728 | |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.83 | 19 | 1,175 | 0 | 19 to 0 (-100.00 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.75 | 4 | 247 | 19 | 23 to 19 (-17.39 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.60 | 33 | 2,033 | 23 | 56 to 23 (-58.93 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.55 | 17 | 1,046 | 56 | 73 to 56 (-23.29 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.30 | 8 | 490 | 73 | 81 to 73 (-9.88 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.25 | 1 | 61 | 81 | 82 to 81 (-1.22 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.19 | 2 | 122 | 82 | 84 to 82 (-2.38 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.18 | 8 | 489 | 84 | 92 to 84 (-8.70 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.11 | 2 | 122 | 92 | 94 to 92 (-2.13 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.10 | 54 | 3,299 | 94 | 148 to 94 (-36.49 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.09 | 10 | 611 | 148 | 158 to 148 (-6.33 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.07 | 8 | 489 | 158 | 166 to 158 (-4.82 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.05 | 6 | 366 | 166 | 172 to 166 (-3.49 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 61.00 | 49 | 2,989 | 172 | 221 to 172 (-22.17 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.96 | 210 | 12,802 | 221 | 431 to 221 (-48.72 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.83 | 2 | 122 | 431 | 433 to 431 (-0.46 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.81 | 4 | 243 | 433 | 437 to 433 (-0.92 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.80 | 10 | 608 | 437 | 447 to 437 (-2.24 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.78 | 3 | 182 | 447 | 450 to 447 (-0.67 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.77 | 3 | 182 | 450 | 453 to 450 (-0.66 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.76 | 6 | 365 | 453 | 459 to 453 (-1.31 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 60.75 | 8 | 486 | 459 | 467 to 459 (-1.71 %) |
Oct 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 21.55 | 467 | 10,064 | 467 | 0 to 467 |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 9.25 | 4,167 | 38,545 | 15,833 | |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 62.61 | 100 | 6,261 | 21,890 | 22 K to 21.9 K (-0.45 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 62.60 | 100 | 6,260 | 21,990 | 22.1 K to 22 K (-0.45 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 62.50 | 800 | 50,000 | 22,090 | 22.9 K to 22.1 K (-3.49 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 62.50 | 4,167 | 260,438 | 22,890 | 27.1 K to 22.9 K (-15.40 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 9.25 | 4,167 | 38,545 | 27,057 | 22.9 K to 27.1 K (+18.20 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.48 | 3,400 | 212,432 | 6,152 | 9.6 K to 6.2 K (-35.59 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.43 | 1,200 | 74,916 | 9,552 | 10.8 K to 9.6 K (-11.16 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.42 | 900 | 56,178 | 10,752 | 11.7 K to 10.8 K (-7.72 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.41 | 600 | 37,446 | 11,652 | 12.3 K to 11.7 K (-4.90 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.40 | 2,000 | 124,800 | 12,252 | 14.3 K to 12.3 K (-14.03 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.35 | 1,100 | 68,585 | 14,252 | 15.4 K to 14.3 K (-7.17 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.29 | 600 | 37,374 | 15,352 | 16 K to 15.4 K (-3.76 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.26 | 100 | 6,226 | 15,952 | 16.1 K to 16 K (-0.62 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.25 | 10,600 | 659,850 | 16,052 | 26.7 K to 16.1 K (-39.77 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.10 | 4,200 | 260,820 | 26,652 | 30.9 K to 26.7 K (-13.61 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.01 | 300 | 18,603 | 30,852 | 31.2 K to 30.9 K (-0.96 %) |
Sep 17 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Sell | S | 62.00 | 5,000 | 310,000 | 31,152 | 36.2 K to 31.2 K (-13.83 %) |
Sep 14 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Option Exercise | M | 30.74 | 2,000 | 61,480 | 17,200 | |
Sep 14 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 63.07 | 125 | 7,884 | 1,590 | 1.7 K to 1.6 K (-7.29 %) |
Sep 14 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 63.05 | 200 | 12,610 | 1,715 | 1.9 K to 1.7 K (-10.44 %) |
Sep 14 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 63.03 | 200 | 12,606 | 1,915 | 2.1 K to 1.9 K (-9.46 %) |
Sep 14 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 63.02 | 300 | 18,906 | 2,115 | 2.4 K to 2.1 K (-12.42 %) |
Sep 14 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Sell | S | 63.00 | 1,175 | 74,025 | 2,415 | 3.6 K to 2.4 K (-32.73 %) |
Sep 14 2004 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Vice President Rese ... | Buy | M | 30.74 | 2,000 | 61,480 | 3,590 | 1.6 K to 3.6 K (+125.79 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 30.74 | 1,423 | 43,743 | 19,075 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 577 | 12,434 | 5,185 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.45 | 167 | 9,928 | 0 | 167 to 0 (-100.00 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.40 | 149 | 8,851 | 167 | 316 to 167 (-47.15 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.18 | 268 | 15,860 | 316 | 584 to 316 (-45.89 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.16 | 93 | 5,502 | 584 | 677 to 584 (-13.74 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.12 | 751 | 44,399 | 677 | 1.4 K to 677 (-52.59 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.02 | 232 | 13,693 | 1,428 | 1.7 K to 1.4 K (-13.98 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.01 | 9 | 531 | 1,660 | 1.7 K to 1.7 K (-0.54 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 59.00 | 275 | 16,225 | 1,669 | 1.9 K to 1.7 K (-14.15 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.99 | 19 | 1,121 | 1,944 | 2 K to 1.9 K (-0.97 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 58.98 | 37 | 2,182 | 1,963 | 2 K to 2 K (-1.85 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 30.74 | 1,423 | 43,743 | 2,000 | 577 to 2 K (+246.62 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 577 | 12,434 | 577 | 0 to 577 |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 13,905 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.45 | 230 | 13,674 | 4,766 | 5 K to 4.8 K (-4.60 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.40 | 204 | 12,118 | 4,996 | 5.2 K to 5 K (-3.92 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.18 | 370 | 21,897 | 5,200 | 5.6 K to 5.2 K (-6.64 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.16 | 125 | 7,395 | 5,570 | 5.7 K to 5.6 K (-2.19 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.12 | 1,035 | 61,189 | 5,695 | 6.7 K to 5.7 K (-15.38 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.02 | 320 | 18,886 | 6,730 | 7.1 K to 6.7 K (-4.54 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.01 | 12 | 708 | 7,050 | 7.1 K to 7.1 K (-0.17 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 59.00 | 377 | 22,243 | 7,062 | 7.4 K to 7.1 K (-5.07 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.99 | 26 | 1,534 | 7,439 | 7.5 K to 7.4 K (-0.35 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.98 | 51 | 3,008 | 7,465 | 7.5 K to 7.5 K (-0.68 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,450 | 24,379 | 35,500 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.45 | 121 | 7,193 | 2,890 | 3 K to 2.9 K (-4.02 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.40 | 108 | 6,415 | 3,011 | 3.1 K to 3 K (-3.46 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.18 | 195 | 11,540 | 3,119 | 3.3 K to 3.1 K (-5.88 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.16 | 67 | 3,964 | 3,314 | 3.4 K to 3.3 K (-1.98 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.12 | 545 | 32,220 | 3,381 | 3.9 K to 3.4 K (-13.88 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.02 | 167 | 9,856 | 3,926 | 4.1 K to 3.9 K (-4.08 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.01 | 8 | 472 | 4,093 | 4.1 K to 4.1 K (-0.20 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 59.00 | 199 | 11,741 | 4,101 | 4.3 K to 4.1 K (-4.63 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.99 | 13 | 767 | 4,300 | 4.3 K to 4.3 K (-0.30 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 58.98 | 27 | 1,592 | 4,313 | 4.3 K to 4.3 K (-0.62 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,450 | 24,379 | 4,340 | 2.9 K to 4.3 K (+50.17 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 7,170 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 30.74 | 7,444 | 228,829 | 48,300 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.45 | 688 | 40,902 | 4,255 | 4.9 K to 4.3 K (-13.92 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.40 | 610 | 36,234 | 4,943 | 5.6 K to 4.9 K (-10.99 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.18 | 1,112 | 65,808 | 5,553 | 6.7 K to 5.6 K (-16.68 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.16 | 382 | 22,599 | 6,665 | 7 K to 6.7 K (-5.42 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.12 | 3,097 | 183,095 | 7,047 | 10.1 K to 7 K (-30.53 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.02 | 955 | 56,364 | 10,144 | 11.1 K to 10.1 K (-8.60 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.01 | 38 | 2,242 | 11,099 | 11.1 K to 11.1 K (-0.34 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 59.00 | 1,131 | 66,729 | 11,137 | 12.3 K to 11.1 K (-9.22 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.99 | 76 | 4,483 | 12,268 | 12.3 K to 12.3 K (-0.62 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 58.98 | 153 | 9,024 | 12,344 | 12.5 K to 12.3 K (-1.22 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 12,497 | 11.7 K to 12.5 K (+6.82 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 30.74 | 7,444 | 228,829 | 11,699 | 4.3 K to 11.7 K (+174.95 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 3,500 | 83,475 | 87,300 | |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 60.38 | 100 | 6,038 | 10,735 | 10.8 K to 10.7 K (-0.92 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 60.36 | 200 | 12,072 | 10,835 | 11 K to 10.8 K (-1.81 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 60.33 | 405 | 24,434 | 11,035 | 11.4 K to 11 K (-3.54 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 60.32 | 600 | 36,192 | 11,440 | 12 K to 11.4 K (-4.98 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 60.29 | 100 | 6,029 | 12,040 | 12.1 K to 12 K (-0.82 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 60.27 | 30 | 1,808 | 12,140 | 12.2 K to 12.1 K (-0.25 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 60.25 | 900 | 54,225 | 12,170 | 13.1 K to 12.2 K (-6.89 %) |
Sep 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 3,500 | 83,475 | 13,070 | 9.6 K to 13.1 K (+36.57 %) |